Fluke Biomedical is pleased to offer its first Medical Device Quality Assurance Training Summit Sept. 16-20 at the North Seattle Community College (NSCC) Biomed Laboratory in Seattle, Wash. The five-day event is designed for entry-level biomeds / field service technicians and engineers, and will utilize a hands-on approach to understanding medical device risk management, and best practices for safety and performance testing.
Minmax Power announced expansion of their M78A and M78SA switching regulators that are pin-compatible and size-compatible with older and less-efficient LM78xx devices.
LTL Color Compounders has introduced a new product line, ColorFast X Series—a proprietary thermoplastic compounds for extruded sheet, profile and film applications.
Saelig Company has introduced the PP877 Three-Axis Accelerometer, which includes a signal-conditioning interface suitable for any 3-input oscilloscope, but is especially suited to Pico Technology's four-channel PC oscilloscope adapters.
Buck Chuck announced the release of their new 20” ATSC scroll chuck to meet the demand for larger chucking options. This manual, self-centering scroll chuck is designed with a high-quality forged steel body construction to provide precision gripping.
A new test has been developed for medical device manufacturers and biomaterials researchers to screen plastics, composites, and polymers for toxicity. This ZET test utilizes zebrafish (Danio rerio). Zebrafish are extensively used in drug development studies due to their transparent embryos and fast development times.
Kent L. Klaudt, lawyer at the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that U.S. District Court Judge G. Murray Snow of the District of Arizona denied in large part Medtronic’s motion to dismiss a personal injury lawsuit brought by Dr. Cristina Ramirez against the company on grounds that the claims are preempted by Federal law.
The real challenge facing life science companies is that meeting these extensive regulatory and quality procedures, codified in cGMP [current good manufacturing practices] regulations burdens companies, delays product rollouts, impedes innovation, and hinders business processes.
The societal and economic savings of knee replacement surgery outweigh its costs nearly 2-fold, according to an American Academy of Orthopaedic Surgeons study. The, study published this week in the peer-reviewed Journal of Bone & Joint Surgery, addresses recent scrutiny of the cost and durability of knee replacement surgery...
Healthcare giant Smith & Nephew (FTSE:SN, NYSE:SNN) came to terms with former staffing services provider Northwest Ortho Plus, putting to bed a year-old trade secrets dispute. The original lawsuit, which accused Northwest of damaging Smith's goodwill and compromising valuable corporate information, was seeking $56 million in damages...
Irvine, Calif. medical device maker Reverse Medical Corp. touted FDA clearance for its flagship product, the MVP micro vascular plug for peripheral artery embolization. The plug helps decrease blood flow in the peripheral vasculature and is "completely re-sheathable" for use in procedures where a patient needs only temporary blood flow reduction.
Zimmer Holdings, Inc., a world leader in musculoskeletal care, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Zimmer® Patient Specific Instruments (PSI) Shoulder system to complement its Trabecular Metal™ Reverse Shoulder system for reverse shoulder arthroplasty (RSA) procedures.
New research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine could aid efforts to diagnose and treat one of the most lethal and hard-to-treat types of cancer. In the EMBO Molecular Medicine journal, the investigators report that they have identified a new molecular mechanism that contributes to the spread of malignant tumors in the pancreas.
In a scientific first, Harvard Stem Cell Institute scientists have successfully grown the cells that line the blood vessels—called vascular endothelial cells—from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.
Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer’s disease, Parkinson’s disease and other brain-damaging disorders.